Fmcna - Kenner Dialysis is a medicare approved dialysis facility center in Kenner, Louisiana and it has 20 dialysis stations. It is located in Jefferson county at 2717 Decatur St, Kenner, LA, 70062. You can reach out to the office of Fmcna - Kenner Dialysis at (504) 469-1075. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Fmcna - Kenner Dialysis has the following ownership type - Profit. It was first certified by medicare in September, 2007. The medicare id for this facility is 192691 and it accepts patients under medicare ESRD program.
| Name | Fmcna - Kenner Dialysis |
|---|---|
| Location | 2717 Decatur St, Kenner, Louisiana |
| No. of Dialysis Stations | 20 |
| Medicare ID | 192691 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 2717 Decatur St, Kenner, Louisiana, 70062 | |
| (504) 469-1075 | |
News Archive
IntraPace, Inc. announced today that it has received CE Mark for the LGL102, a new gastric stimulation/food sensing lead designed to work with the innovative abiliti system, an implantable weight loss management system.
Young children diagnosed with a malignant type of brain tumour will benefit from research that has taken twelve years to complete.
The drug daclatasvir (trade name Daklinza) has been available since August 2014 for the treatment of adults with chronic hepatitis C (CHC) infection. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy.
The future is here: everyday healthcare is now intertwined with technology at every level. From improved record-keeping to smartphone apps that patients can use to track health progress, the technological infrastructure that has grown up around healthcare provides benefits that the previous generation couldn't dream of.
› Verified 1 days ago
| NPI Number | 1447381280 |
| Organization Name | Fresenius Medical Care Kenner |
| Doing Business As | Bio-medical Applications Of Louisiana Llc |
| Address | 2717 Decatur Street Kenner, Louisiana, 70062 |
| Phone Number | (504) 469-1075 |
News Archive
IntraPace, Inc. announced today that it has received CE Mark for the LGL102, a new gastric stimulation/food sensing lead designed to work with the innovative abiliti system, an implantable weight loss management system.
Young children diagnosed with a malignant type of brain tumour will benefit from research that has taken twelve years to complete.
The drug daclatasvir (trade name Daklinza) has been available since August 2014 for the treatment of adults with chronic hepatitis C (CHC) infection. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy.
The future is here: everyday healthcare is now intertwined with technology at every level. From improved record-keeping to smartphone apps that patients can use to track health progress, the technological infrastructure that has grown up around healthcare provides benefits that the previous generation couldn't dream of.
› Verified 1 days ago
| Dialysis patients with Hemoglobin data | 41 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 5 |
News Archive
IntraPace, Inc. announced today that it has received CE Mark for the LGL102, a new gastric stimulation/food sensing lead designed to work with the innovative abiliti system, an implantable weight loss management system.
Young children diagnosed with a malignant type of brain tumour will benefit from research that has taken twelve years to complete.
The drug daclatasvir (trade name Daklinza) has been available since August 2014 for the treatment of adults with chronic hepatitis C (CHC) infection. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy.
The future is here: everyday healthcare is now intertwined with technology at every level. From improved record-keeping to smartphone apps that patients can use to track health progress, the technological infrastructure that has grown up around healthcare provides benefits that the previous generation couldn't dream of.
› Verified 1 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 64 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 571 |
| Percentage of adult patients getting regular hemodialysis at the center | 96 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
IntraPace, Inc. announced today that it has received CE Mark for the LGL102, a new gastric stimulation/food sensing lead designed to work with the innovative abiliti system, an implantable weight loss management system.
Young children diagnosed with a malignant type of brain tumour will benefit from research that has taken twelve years to complete.
The drug daclatasvir (trade name Daklinza) has been available since August 2014 for the treatment of adults with chronic hepatitis C (CHC) infection. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy.
The future is here: everyday healthcare is now intertwined with technology at every level. From improved record-keeping to smartphone apps that patients can use to track health progress, the technological infrastructure that has grown up around healthcare provides benefits that the previous generation couldn't dream of.
› Verified 1 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Fmcna - Kenner Dialysis with elevated calcium levels.
| Patients with hypercalcemia | 66 |
| Hypercalcemia patient months | 595 |
| Patients with Serumphosphor | 70 |
| Patients with Serumphosphor less than 3.5 mg/dL | 9 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 25 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 27 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 26 |
| Patients with Serumphosphor greater than 7 mg/dL | 13 |
News Archive
IntraPace, Inc. announced today that it has received CE Mark for the LGL102, a new gastric stimulation/food sensing lead designed to work with the innovative abiliti system, an implantable weight loss management system.
Young children diagnosed with a malignant type of brain tumour will benefit from research that has taken twelve years to complete.
The drug daclatasvir (trade name Daklinza) has been available since August 2014 for the treatment of adults with chronic hepatitis C (CHC) infection. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy.
The future is here: everyday healthcare is now intertwined with technology at every level. From improved record-keeping to smartphone apps that patients can use to track health progress, the technological infrastructure that has grown up around healthcare provides benefits that the previous generation couldn't dream of.
› Verified 1 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 66 |
| Patient months included in arterial venous fistula and catheter summaries | 490 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 60 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 14 |
News Archive
IntraPace, Inc. announced today that it has received CE Mark for the LGL102, a new gastric stimulation/food sensing lead designed to work with the innovative abiliti system, an implantable weight loss management system.
Young children diagnosed with a malignant type of brain tumour will benefit from research that has taken twelve years to complete.
The drug daclatasvir (trade name Daklinza) has been available since August 2014 for the treatment of adults with chronic hepatitis C (CHC) infection. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy.
The future is here: everyday healthcare is now intertwined with technology at every level. From improved record-keeping to smartphone apps that patients can use to track health progress, the technological infrastructure that has grown up around healthcare provides benefits that the previous generation couldn't dream of.
› Verified 1 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 51 |
| Hospitalization Rate in facility | 79.4 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 185.9 |
| Hospitalization Rate: Lower Confidence Limit | 36 |
News Archive
IntraPace, Inc. announced today that it has received CE Mark for the LGL102, a new gastric stimulation/food sensing lead designed to work with the innovative abiliti system, an implantable weight loss management system.
Young children diagnosed with a malignant type of brain tumour will benefit from research that has taken twelve years to complete.
The drug daclatasvir (trade name Daklinza) has been available since August 2014 for the treatment of adults with chronic hepatitis C (CHC) infection. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy.
The future is here: everyday healthcare is now intertwined with technology at every level. From improved record-keeping to smartphone apps that patients can use to track health progress, the technological infrastructure that has grown up around healthcare provides benefits that the previous generation couldn't dream of.
› Verified 1 days ago
The rate of readmission show you whether patients who were being treated regularly at Fmcna - Kenner Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 14.6 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 30.3 |
| Readmission Rate: Lower Confidence Limit | 5.2 |
News Archive
IntraPace, Inc. announced today that it has received CE Mark for the LGL102, a new gastric stimulation/food sensing lead designed to work with the innovative abiliti system, an implantable weight loss management system.
Young children diagnosed with a malignant type of brain tumour will benefit from research that has taken twelve years to complete.
The drug daclatasvir (trade name Daklinza) has been available since August 2014 for the treatment of adults with chronic hepatitis C (CHC) infection. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy.
The future is here: everyday healthcare is now intertwined with technology at every level. From improved record-keeping to smartphone apps that patients can use to track health progress, the technological infrastructure that has grown up around healthcare provides benefits that the previous generation couldn't dream of.
› Verified 1 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Fmcna - Kenner Dialysis get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .87 (As Expected) |
| SIR: Upper Confidence Limit | 2.37 |
| SIR: Lower Confidence Limit | .22 |
News Archive
IntraPace, Inc. announced today that it has received CE Mark for the LGL102, a new gastric stimulation/food sensing lead designed to work with the innovative abiliti system, an implantable weight loss management system.
Young children diagnosed with a malignant type of brain tumour will benefit from research that has taken twelve years to complete.
The drug daclatasvir (trade name Daklinza) has been available since August 2014 for the treatment of adults with chronic hepatitis C (CHC) infection. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy.
The future is here: everyday healthcare is now intertwined with technology at every level. From improved record-keeping to smartphone apps that patients can use to track health progress, the technological infrastructure that has grown up around healthcare provides benefits that the previous generation couldn't dream of.
› Verified 1 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Fmcna - Kenner Dialysis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 44 |
| Transfusion Rate in facility | 29 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 101.1 |
| Transfusion Rate: Lower Confidence Limit | 9.7 |
News Archive
IntraPace, Inc. announced today that it has received CE Mark for the LGL102, a new gastric stimulation/food sensing lead designed to work with the innovative abiliti system, an implantable weight loss management system.
Young children diagnosed with a malignant type of brain tumour will benefit from research that has taken twelve years to complete.
The drug daclatasvir (trade name Daklinza) has been available since August 2014 for the treatment of adults with chronic hepatitis C (CHC) infection. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy.
The future is here: everyday healthcare is now intertwined with technology at every level. From improved record-keeping to smartphone apps that patients can use to track health progress, the technological infrastructure that has grown up around healthcare provides benefits that the previous generation couldn't dream of.
› Verified 1 days ago
The rate of mortality show you whether patients who were being treated regularly at Fmcna - Kenner Dialysis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 225 |
| Mortality Rate in facility | 16.7 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 23.8 |
| Mortality Rate: Lower Confidence Limit | 11.2 |
News Archive
IntraPace, Inc. announced today that it has received CE Mark for the LGL102, a new gastric stimulation/food sensing lead designed to work with the innovative abiliti system, an implantable weight loss management system.
Young children diagnosed with a malignant type of brain tumour will benefit from research that has taken twelve years to complete.
The drug daclatasvir (trade name Daklinza) has been available since August 2014 for the treatment of adults with chronic hepatitis C (CHC) infection. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy.
The future is here: everyday healthcare is now intertwined with technology at every level. From improved record-keeping to smartphone apps that patients can use to track health progress, the technological infrastructure that has grown up around healthcare provides benefits that the previous generation couldn't dream of.
› Verified 1 days ago
Davita - Kenner Reg Dialysis Location: 200 W Esplanade Ste 100, Kenner, Louisiana, 70065 Phone: (504) 471-0931 |
FKC - Kenner Home Therapies Location: 3409 Williams Blvd, Suite 2, Kenner, Louisiana, 70065 Phone: (504) 305-1980 |
News Archive
IntraPace, Inc. announced today that it has received CE Mark for the LGL102, a new gastric stimulation/food sensing lead designed to work with the innovative abiliti system, an implantable weight loss management system.
Young children diagnosed with a malignant type of brain tumour will benefit from research that has taken twelve years to complete.
The drug daclatasvir (trade name Daklinza) has been available since August 2014 for the treatment of adults with chronic hepatitis C (CHC) infection. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy.
The future is here: everyday healthcare is now intertwined with technology at every level. From improved record-keeping to smartphone apps that patients can use to track health progress, the technological infrastructure that has grown up around healthcare provides benefits that the previous generation couldn't dream of.
› Verified 1 days ago